Episode #21 - This one number can make or break careers and companies
If we told you that a century-old statistical test still rules scientific careers and costs (or makes) companies millions of dollars, wouldn't you won...
Signal
Share:
Listens: 20
About
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures. But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives. Where will the next breakthroughs come from? How will we pay for them? Who decides who gets them? This is SIGNAL, a podcast from Stat that sorts through the flood of health and medical news to deliver stories of the next development, controversy or breakthrough that will affect us all. Hosted by veteran biotech journalist Luke Timmerman and CNBC biotech and pharma reporter Meg Tirrell, SIGNAL explores the characters and the dramas behind today’s medicine, from biotech boardrooms, to research labs, to your corner pharmacy. Subscribe to us on iTunes and Stitcher, or visit us on our website, www.statnews.com.
Episode #20 - The death of a child and a golden ticket for drug makers
How did every parent's worst nightmare — the death of their child — spur the creation of an incentive system to turn making drugs for childhood cancer...
Episode #19 - From poop transplants to the politics of pills — a year in Signal
The Signal podcast is now one year old. And in our first year, we've been able to cover so much truly fascinating science. It's also clear to us how m...
Episode #18 - Election Day Special: How our next president could affect drug prices
Today, as Americans head to the polls — and wait for the returns to start coming in — we’re going to take a look back to what history can tell us abou...
Episode #17 - Will a new gene editing technology turn out to be Pandora's box in a bottle?
What if you could stop mosquito-borne diseases before you ever needed to make medicines to treat them? And what if the seeds of destruction for dengue...
Episode #16 - How drug companies use monopoly shenanigans to make big profits
We take a deep dive into some of the nefariously creative tricks drug companies use to maintain monopolies and handle competition. This Signal podcast...
Episode #15 - In a race between science and Zika, who wins?
In today's show, we take you on a Zika odyssey to meet some odd and unexpected characters, from helpful horses to genetically modified mosquitoes prog...
Episode #14 - These hamsters have birthed billions for biotech
The Chinese hamster has led a secret life in science for decades. By one estimate, 11 biotech drugs that are made using Chinese hamster ovary cells ge...
Episode #13 - The superbugs are quietly amassing their forces -- and we're helping them
A deadly new superbug is just starting to surface worldwide. Who is to blame for its rise? Well, us, really. Public health officials are warning we co...
Episode #12 - Before you pop that Tylenol, listen to this podcast
How confident are you that the drugs you take, whether they're over-the-counter or prescription, are totally understood by the companies who make them...